In adult mammalian brains, neurogenesis persists in the subventricular zone of the lateral ventricles (SVZ) and the dentate gyrus (DG) of the hippocampus. Although evidence suggest that adult neurogenesis in these two regions is subjected to differential regulation, the underlying mechanism is unclear. Here, we show that the RNA-binding protein FXR2 specifically regulates DG neurogenesis by reducing the stability of Noggin mRNA. FXR2 deficiency leads to increased Noggin expression and subsequently reduced BMP signaling, which results in increased proliferation and altered fate specification of neural stem/progenitor cells in DG. In contrast, Noggin is not regulated by FXR2 in the SVZ, because Noggin expression is restricted to the ependymal cells of the lateral ventricles, where FXR2 is not expressed. Differential regulation of SVZ and DG stem cells by FXR2 may be a key component of the mechanism that governs the different neurogenic processes in these two adult germinal zones.
INTRODUCTION
Adult mammalian brains have two neurogenic regions: the subgranular zone of the dentate gyrus (DG) of the hippocampus, which generates excitatory glutamatergic granule neurons in the DG, and the subventricular zone (SVZ) of the lateral ventricles, which produces inhibitory GABAergic and dopaminergic interneurons of the olfactory bulb (Lledo et al., 2006; Ming and Song, 2005; Mu et al., 2010) . Since the discovery of adult neurogenesis, DG and SVZ neurogenesis have been known to respond differently to neurotrophic factors treatment and physiological and pathological conditions Zhao et al., 2008) . For example, environmental enrichment and physical activity boost neurogenesis in the DG, but not in the SVZ (Brown et al., 2003; Kempermann et al., 1997; Nilsson et al., 1999) . In addition, cranial irradiation represses cell proliferation in both the SVZ and DG, but the DG suffers long-term effects, whereas the SVZ recovers with time (Hellstrom et al., 2009) .
Although multipotent neural stem/progenitor cells (NPCs) exist widely in adult brains, neurogenesis is known to be restricted by the local stem cell niche (Goldman, 2004; Mu et al., 2010; Zhao et al., 2008) . However, recent literature suggests that NPCs residing in different regions of the brain may be intrinsically programmed to differentiate into restricted types of neurons (Merkle et al., 2007) . NPCs derived from the adult SVZ (SVZ-NPCs) are shown to have better self-renewal capability than do NPCs derived from the adult DG (DG-NPCs) (Bull and Bartlett, 2005; Seaberg and van der Kooy, 2002) , which could be due to their intrinsic differences in BMP signaling (Bonaguidi et al., 2008) . Nonetheless, despite these observations, the precise molecular mechanism underlying the differential regulation of SVZ and DG neurogenesis is still largely a mystery.
Fragile X relative protein 2 (FXR2) belongs to a family of fragile X mental retardation proteins (FMRP, FXR1, and FXR2) that can bind to RNA and associate with polyribosomes (Darnell et al., 2009 ). These proteins share high sequence similarity in certain functional domains but diverge in the C termini and in the nucleolar localization signal sequence, suggesting that they may possess both overlapping and distinct functions (Coffee et al., 2010; Kirkpatrick et al., 2001) . FMRP and FXR2 are highly enriched in mammalian brains (Agulhon et al., 1999; Bakker et al., 2000) . Although only FMRP deficiency has been linked to human fragile X syndrome, both FMRP and FXR2 mutant (KO) mice exhibit fragile X-like behavioral deficits, including hippocampus-dependent learning impairment. Furthermore, FXR2 and FMRP double-mutant mice display exaggerated learning deficits compared with single mutant mice (Bontekoe et al., 2002; Brennan et al., 2006; Hayashi et al., 2007; Spencer et al., 2006; Zhao et al., 2005) . Since FMRP deficiency affects adult hippocampal neurogenesis (Guo et al., 2011; Luo et al., 2010) , the behavioral phenotype of Fxr2 KO mice suggests that FXR2 may also regulate adult neurogenesis. Interestingly, Fxr2 KO mice display learning impairments and changes in synaptic plasticity that are somewhat distinct from those of FMRP-deficient mice Zhang et al., 2009) , indicating that FXR2 may also regulate adult hippocampal neurogenesis via mechanisms distinct from FMRP . Until now, the role of FXR2 in the adult brain has not been well studied, and its role in adult neurogenesis remains unexplored.
Here, we show that FXR2 deficiency leads to altered stem cell proliferation and differentiation specifically in the DG and not in the SVZ. We find that, in DG-NPCs, FXR2 represses the expression of Noggin, an antagonist of BMP signaling. Either reducing the action of Noggin or enhancing BMP signaling rescues the stem cell phenotypes resulting from FXR2 deficiency. In the SVZ, however, Noggin expression is restricted to ependymal cells, where FXR2 is not expressed; therefore, Noggin expression is not regulated by FXR2. Our study reveals a regulatory mechanism of adult hippocampal neurogenesis by the brain-enriched RNA-binding protein FXR2. The differential regulation of SVZ and DG stem cells by FXR2 may be a key component of the mechanism governing the differential neurogenic processes in these two adult germinal zones.
RESULTS

FXR2
Deficiency Affects NPC Proliferation and Differentiation in the DG but Not in the SVZ To investigate the role of FXR2 in adult neural stem cells, we first demonstrated that FXR2 is indeed expressed in the two adult germinal zones, SVZ ( Figure 1A ) and the DG ( Figure 1B ). We detected FXR2 expression in most of the granule neurons in the DG with no compensatory increased expression of FMRP in Fxr2 KO mice (see Figure S1A available online), which is consistent with the literature (Bakker et al., 2000; Bontekoe et al., 2002 Figures S1C-S1E ). To explore the function of FXR2 in adult neurogenesis, we assessed the proliferation and differentiation of NPCs in Fxr2 KO mice and wild-type (WT) controls using a saturation BrdU pulse-labeling method that could label the entire pool of proliferating NPCs within a 12 hr period ( Figure 2A ) (Hayes and Nowakowski, 2002; Luo et al., 2010) . Quantitative analysis at 12 hr following the last BrdU injection showed that, in the DG of the hippocampus, Fxr2 KO mice had $20% more BrdU + cells compared with WT littermates (Figures 2B and 2C ; n = 6, p < 0.05). Nestin + immature cells in the DG are known to contain at least two populations: Nestin + GFAP + radial glia-like cells (also called type 1; Figure 2D ) and Nestin + GFAP À nonradial glia-like cells (also called type 2a; Figure 2G ). Both types can incorporate BrdU (Ables et al., 2010; Kempermann et al., 2004; Ming and Song, 2005 (Figures 2I and 2J ; n = 6, p < 0.001). Therefore, FXR2 deficiency leads to enhanced proliferation and neuronal differentiation of NPCs in the DG, without affecting the short-term survival of new cells. We then assessed neurogenesis in the SVZ of adult Fxr2 KO mice. To our surprise, Fxr2 KO mice showed no significant differences in BrdU incorporation ( Figure 2K ; n = 5, p = 0.525) and the proliferation of either Nestin + GFAP + cells ( Figure 2L ; n = 6, p = 0.6472) or Nestin + GFAP À cells (n = 6, p = 0.8538) compared to WT mice. Furthermore, at one week after BrdU injection, the percentage of DCX + neuroblasts among BrdU + cells in the rostral migratory stream (RMS, Figure 2M ) was essentially the same for WT and Fxr2 KO mice (n = 5, p = 0.8871). Taken together, these results suggest that the loss of FXR2 specifically alters neurogenesis in the adult DG, but not in the adult SVZ.
Regulates the Proliferation and Differentiation of NPCs Derived from the Adult DG, but Not Those from the SVZ To determine whether the different phenotypes in the DG and SVZ in the Fxr2 KO mice were due to intrinsic differences in NPCs, we isolated NPCs from both regions ( Figures 3A and  3J ). Early passage primary NPCs isolated from both DG and SVZ were positive for the progenitor markers Nestin and Sox2 ( Figure 3B ) and expressed FXR2 ( Figure S2A and S2B). In fact, 96.7% ± 0.84% of total cultured NPCs and 98.8% ± 0.82% of Nestin + Sox2 + NPCs expressed FXR2 ( Figure S2C ). We found that Fxr2 KO DG-NPCs exhibited significantly higher BrdU incorporation compared with WT cells, particularly in the Sox2/Nestin double-positive populations (Figures 3C and 3D ; n = 3, p < 0.05). In addition, DG-NPCs isolated from Fxr2 KO brains yielded $25% more primary neurospheres that were $40% larger (in diameter) than WT controls (Figures 3E-3G ; n = 3, p < 0.001). To determine the self-renewal capability of these neurospheres, primary spheres were individually dissociated into single cells and plated at clonal density. Fxr2 KO DGNPCs yielded $40% more secondary and tertiary spheres with $30% increased size compared to WT cells (Figures 3H and  3I ; n = 3, p < 0.001). These results indicate that FXR2 deficiency leads to increased proliferation and self-renewal of DG-NPCs. However, SVZ-NPCs derived from WT and Fxr2 KO mice ( Figure 3J ) had the same BrdU incorporation rate (n = 3, p = 0.8268) and displayed the same primary neurosphere formation as well as similar self-renewal abilities (n = 3, p > 0.05; Figures  S2D-S2F ). Therefore, FXR2 deficiency does not affect the selfrenewal of SVZ-NPCs. Consistent with our in vivo findings, Fxr2 KO DG-NPCs exhibited a $30% increase in neuronal differentiation (Figures 4A and 4B ; n = 3, p < 0.001) and a $60% decrease in astrocyte differentiation (Figures 4D and 4E ; n = 3, p < 0.001) compared with WT controls. The reduction in astrocyte differentiation was not a result of increased death of GFAP + astrocytes (Figures S2G and S2H) . To validate our immunocytochemical data, we assessed differentiation of NPCs by measuring the promoter activity of a pan-neuronal transcription factor, Neurogenic differentiation 1 (NeuroD1) and the promoter activity of astrocyte GFAP (Liu et al., 2010; Luo et al., 2010) . In Fxr2 KO DG-NPCs, NeuroD1 promoter activity increased by $30% ( Figure 4C ; n = 3, p < 0.05), while GFAP promoter activity decreased by $70% ( Figure 4F ; n = 3, p < 0.001). On the other hand, SVZ-NPCs derived from Fxr2 KO mice showed no significant difference in either neuronal or astrocyte differentiation compared with WT cells (n = 3, p > 0.5). Next, we found that expressing exogenous FXR2 in Fxr2 KO DG-NPCs rescued the proliferation ( Figure 4G ; n = 3, p < 0.05), neuronal differentiation ( Figure 4H ; n = 3, p < 0.05), and astrocyte differentiation ( Figure 4I ; n = 3, p < 0.05) deficits of Fxr2 KO DG-NPCs. Therefore, FXR2 regulation of DG-NPCs is likely intrinsic to the NPCs. Even though Fxr2 KO mice exhibit no obvious deficits during embryonic development (Bontekoe et al., 2002) , FXR2 deficiency may nonetheless have a developmental impact on adult NPCs. We therefore acutely knocked down FXR2 in adult DG-NPCs using lentivirus expressing a small inhibitory RNA against FXR2 (shFXR2; Figure S3A ), which resulted in increased proliferation, increased neuronal differentiation, and decreased astrocyte differentiation (Figures S3B-S3D; n = 3, p < 0.05). We then acutely deleted FXR2 in NPCs in the DG of the adult WT mice using retrovirus that only infected dividing cells (Liu et al., 2010; Smrt et al., 2010) (Figures S3E-S3H ). Viral infection resulted in increased proliferation (Figures S3I-S3M) and increased neuronal differentiation ( Figure S3N ). Therefore, acute knockdown of FXR2 in adult NPCs results in phenotypes similar to those we observed in Fxr2 KO NPCs, both in vitro and in vivo. Taken together, our results provide further evidence that FXR2 plays a role in regulating the proliferation and differentiation of NPCs specifically in the adult DG.
FXR2 Represses Noggin Protein Expression in DG-NPCs
To determine how FXR2 regulates NPCs in the DG, we first used real-time PCR-based neural stem cell pathway arrays to identify genes that exhibited altered expression levels in Fxr2 KO DG-NPCs relative to WT cells ( Figure S4A ). Among the genes with >2-fold changes in Fxr2 KO DG-NPCs ( Figure S4B ), we selected Shh (sonic hedgehog), Notch2 (Notch gene homolog 2), Sox3 (SRY-box containing gene 3), and Noggin for further (K) Examples of WT and Fxr2 KO brain sections stained with an antibody against BrdU (red) for in vivo SVZ cell proliferation and differentiation analyses at 12 hr after BrdU injection. Scale bars = 20 mm. (L) Brain regions containing the SVZ were labeled with antibodies against Nestin (green), GFAP (white), and BrdU (red) at 12 hr after BrdU injection. Scale bars = 20 mm. (M) Brain sections containing the rostral migratory stream (RMS) were stained with antibodies against DCX (green) and BrdU (red) at one week after BrdU injection. Data are presented as mean ± SEM; *p < 0.05, **p < 0.01, Student's t test. Scale bars = 20 mm.
analyses, due to their well-known functions in NPCs (Lim et al., 2000; Ninkovic and Gotz, 2007; Palma et al., 2005; Solecki et al., 2001; Wang et al., 2006) . The up-regulation of Noggin in Fxr2 KO DG-NPCs was particularly interesting, because Noggin has been shown to promote the self-renewal of DG-NPCs, but not SVZ-NPCs (Bonaguidi et al., 2008) .
FXR2 is known to bind mRNAs and regulate protein translation (Darnell et al., 2009; Kirkpatrick et al., 2001) . Using immunoprecipitation of FXR2 and its bound RNAs (RNA-IP), we confirmed that FXR2 bound to Noggin mRNA ( Figures 5A and 5B) but not to Shh, Notch2, or Sox3 mRNAs ( Figure S4C ). In addition, biotin-labeled synthetic Noggin mRNA indeed bound FXR2 protein in NSC protein lysate, whereas an antisense control RNA did not ( Figure 5C ). Furthermore, on separately isolated DGNPCs, we confirmed that Noggin mRNA levels were elevated in the Fxr2 KO DG-NPCs ( Figure 5D ). The increased Noggin mRNA levels could be due to either increased gene transcription or increased mRNA stability. We treated WT and KO NPCs with actinomycin D to inhibit gene transcription and found that Noggin mRNA had a longer half-life in Fxr2 KO DG-NPCs than in WT cells ( Figure 5E ; n = 3), while the half-life of Notch2, Shh, and Sox3 mRNA showed no significant difference ( Figures  S4D-S4F ). We then manipulated FXR2 levels in WT and Fxr2 KO DG-NPCs and found that acute knockdown of FXR2 in WT NPCs resulted in a longer half-life of Noggin mRNA, while exogenous FXR2 reduced the Noggin mRNA half-life in Fxr2 KO DGNPCs ( Figure 5E ). Therefore, FXR2 expression levels directly affect the stability of Noggin mRNA in DG-NPCs. Finally, we confirmed that primary DG-NPCs express both FXR2 and Noggin protein ( Figure S5A ) and that the level of Noggin protein was significantly higher in both the cell lysate and the conditioned medium of Fxr2 KO DG-NPCs, compared with WT cells (Figures 5F and 5G) . Therefore, FXR2 represses Noggin protein expression in DG-NPCs by decreasing the half-life of Noggin mRNA.
Noggin inhibits BMP signaling by preventing BMP from interacting with their receptors ( Figure 5H ) (Klingensmith et al., 2010; Rosen, 2006) . Accordingly, we assessed the activity of the BMP signaling in Fxr2 KO DG-NPCs by analyzing the phosphorylation of Smad1/5 (p-Smad1/5), an indicator of BMP pathway activation (Miyazono et al., 2005) . We found that KO DG-NPCs had a reduced ratio of p-Smad1/5 compared with total Smad1/5 ( Figure 5I ). Introducing exogenous FXR2 into Fxr2 KO DG-NPCs resulted in rescue of both secreted Noggin protein levels ( Figure 5J ) and p-Smad1/5 levels ( Figure 5K; Figure S5B ). On the other hand, acute knockdown of FXR2 in WT DG-NPCs resulted in increased secreted Noggin protein (Figure 5L) , as well as reduced p-Smad1/5 ( Figure 5M ; Figure S5C ). Therefore, FXR2 regulates the BMP signaling in DG-NPCs by controlling Noggin levels.
Since FXR2 is highly expressed in DG neurons, we also assessed BMP signaling in hippocampal tissue ( Figures S5D-S5F ). Indeed, Noggin protein levels were significantly higher ( Figure S5G ), while p-Smad1/5 levels were significantly lower ( Figure S5H ) in the hippocampal tissue of Fxr2 KO mice compared with WT mice. Thus, by inhibiting Noggin protein expression, FXR2 promotes BMP signaling in both DG-NPCs and in the hippocampus.
Manipulating BMP Signaling Rescues Deficits in FXR2-Deficeient DG-NPCs
We reasoned that either adding exogenous BMP2 or blocking endogenous Noggin should rescue the phenotypes of Fxr2 KO DG-NPCs ( Figure 6A ). Indeed, BMP2 treatment reduced the high proliferation rate of Fxr2 KO DG-NPCs (Figures 6B and  6C ; n = 3) and rescued both the neuronal (Figures 6D and 6E ; n = 3) and astrocyte (Figures 6F and 6G ; n = 3) differentiation phenotypes of Fxr2 KO DG-NPCs to the WT control levels. In addition, an anti-Noggin blocking antibody rescued the proliferation and differentiation deficits of Fxr2 KO DG-NPCs (Figures  6H-6K ; n = 3). Next, to confirm that enhanced Noggin expression by Fxr2 KO DG-NPCs indeed had a biological effect on NPC functions, we treated WT DG-NPCs with conditioned medium collected from Fxr2 KO DG-NPCs. The conditioned medium from KO cells promoted the proliferation of WT cells, which could be blocked by an anti-Noggin blocking antibody ( Figure S5I and S5J). Therefore, Noggin and BMP signaling are likely downstream effectors of FXR2 in the regulation of DG neurogenesis. Noggin has been shown to promote the self-renewal of type 1 cells in the DG (Bonaguidi et al., 2008) . We therefore hypothesized that elevated Noggin levels might be responsible for the increased cell proliferation we observed in Fxr2 KO mice. Accordingly, we investigated whether reducing endogenous Noggin in the DG could rescue the neurogenic phenotype of Fxr2 KO mice (Figures S6A-S6C) . The lentivirus expressing either a shRNA against Noggin (shNog) or a control shRNA (shNC), as well as GFP, were injected into the DG of Fxr2 KO and WT littermates ( Figure 7A ) based on a published protocol (Clelland et al., 2009) . We waited for two weeks after lentiviral grafting to allow for sufficient depletion of endogenous Noggin before giving mice BrdU. We saw that, in animals with successful viral grafting, which therefore were used for data analysis, a large number of DG cells were infected by the recombinant lentivirus in both WT and KO mice (GFP + cells in Figure S6D and Figures 7B, 7F, and 7I). Lenti-shNog-infected cells had reduced levels of Noggin protein ( Figure S6E ). As expected, reduction of Noggin in the DG had a significant effect on the proliferation of DGNPCs, as assessed at both 12 hr ( Figure 7C ) and one week (Figure 7D ) after BrdU injection, with no effect on the survival of BrdU + cells ( Figure 7E ). The effect of shNog on cell proliferation was, at least in part, due to its effect on the GFAP + radial glia-like population (Figures 7F-7H ; Figure S6F ), which is similar to the function of FXR2. In addition, acute knockdown of Noggin resulted in enhanced neuronal differentiation of adult NPCs and, hence, enhanced the number of new neurons analyzed at one week after BrdU injection ( Figures 7I-7K ). Furthermore, knocking down endogenous Noggin in adult Fxr2 KO mice (KO+shNog) led to significantly decreased NPC proliferation ( Figures 7C-7H ) and neuronal differentiation ( Figures 7J and 7K ) to levels similar to WT controls (WT+shNC). These in vivo data further support the model that FXR2 regulates DG neurogenesis by repressing Noggin protein levels.
FXR2 and Noggin Colocalize in DG but Not in SVZ Cells
Next, we investigated why FXR2 deficiency had no effect on SVZ-NPCs. Although FXR2 was expressed at comparable levels in both SVZ-NPCs and DG-NPCs, we were only able to detect extremely low levels of Noggin protein in SVZ-NPCs, and the expression levels of Noggin were no different between cultured WT and KO SVZ-NPCs ( Figure S7A ). In addition, KO SVZNPCs did not show altered p-Smad1/5 levels compared with WT cells (Figure S7B ), suggesting that FXR2 deficiency does not alter either Noggin expression or BMP signaling in SVZ-NPCs. The lack of effect from FXR2 deficiency on Noggin and BMP signaling in SVZ-NPCs could have two possible explanations: (1) Noggin and the BMP pathway do not regulate the functions of SVZ cells as they do in the case of DG cells; or (2) FXR2 does not regulate Noggin expression, and therefore BMP signaling in SVZ cells as it does in DG cells.
To distinguish between these two hypotheses, we first assessed the effects of exogenous Noggin and BMP2 on SVZ-NPCs, compared with DG-NPCs. We found that exogenous Noggin promoted the proliferation of DG-NPCs ( Figure S7F ), but not SVZ-NPCs (Figure S7C ), consistent with literature (Bonaguidi et al., 2008; Lim et al., 2000) . On the other hand, Noggin promoted neuronal differentiation and decreased astrocyte differentiation in both SVZ-NPCs ( Figures S7D and S7E ) and DG-NPCs ( Figures S7G and S7H ) to similar extents, consistent with its reported role in inhibiting glia cell fate (Chmielnicki et al., 2004; Kohyama et al., 2010; Lim et al., 2000) . We then found that exogenous BMP2 inhibited proliferation, repressed neuronal differentiation, and promoted astrocyte fate to similar extents in both WT and KO SVZ-NPCs ( Figures S7I-S7K ). Therefore, BMP2 had similar effects on both DG-NPCs ( Figures 6B-6G ) and SVZ-NPCs. We therefore predicted that FXR2 must not regulate Noggin expression in SVZ-NPCs as it does in DG-NPCs.
To assess this possibility, we first confirmed that FXR2 indeed does not bind Noggin mRNA in SVZ-NPCs ( Figure S7L ). Because FXR2 and Noggin are expressed in both the DG and SVZ, we reasoned that a lack of FXR2 regulation of Noggin in the SVZ might be due to cell type-restricted expression of these two proteins. To precisely identify the cells expressing Noggin, we used both Noggin antibody staining and a transgenic ''knockin'' mouse strain expressing b-gal under the Noggin promoter (Noggin lacZ ) (McMahon et al., 1998) . Expression of b-gal in this strain is an accurate and precise reporter of Noggin expression (Stottmann et al., 2001 ). Indeed, we found that FXR2 and Noggin are not colocalized in the same cells in the SVZ ( Figure 8A ; Figures S8A-S8C ). Noggin expression is restricted to s100b + ependymal cells that also express Nestin ( Figures 8B and 8C , Figure S8B ), consistent with a previous report (Lim et al., 2000) . By contrast, FXR2 is expressed only in s100b-negative NPCs (Figures 1, 8A , and 8C; Figure S8C ), and not in s100b + Nestin + ependymal cells (Figures 8A and 8B ; Figure S8A ). In the DG, however, we found that Noggin is expressed in Nestin + GFAP + radial glia-like NPCs ( Figure 8E ; Figures S8E and S8G), consistent with an earlier study (Bonaguidi et al., 2008) . Importantly, these cells also express FXR2 (Figure 1) , and FXR2 expression colocalizes with Noggin in both NPCs and neurons of the DG ( Figure 8D ; Figures S8D and S8F ). These spatiotemporal expression data further support the regulatory role of FXR2 in DGNPCs, but not in SVZ-NPCs. Taken together, our data argue for a model in which FXR2 specifically regulates DG-NPCs by directly repressing Noggin expression in DG-NPCs. Because Noggin expression in the SVZ is not regulated by FXR2, FXR2 deficiency therefore has minimal impact on SVZ-NPCs ( Figures 8F and 8G ).
(G) Conditioned medium from Fxr2 KO DG-NPCs displayed significantly elevated Noggin levels determined using an ELSA assay (n = 3, p < 0.05). 
DISCUSSION
The molecular mechanism behind the differential regulation of SVZ and DG neurogenesis has gone largely unexplored. By unveiling a regulatory mechanism involving FXR2 that governs adult hippocampal neurogenesis, our data show that a brain-enriched RNA-binding protein could play important roles in the differential regulation of NPCs residing in different brain regions. Both the Extrinsic Stem Cell Niche and Intrinsic NPC Properties May Contribute to the Differences between Adult DG and SVZ Neurogenesis A limited number of publications have analyzed both DG and SVZ neurogenesis and reported different phenotypes between these two regions (Belvindrah et al., 2002; Liu et al., 2007) . However, the molecular mechanism underlying the differences between DG and SVZ neurogenesis is largely a mystery.
The cytoarchitecture of the two adult neurogenic regions are quite different. There are four key cell types in the SVZ: ciliated ependymal cells that face the ventricle lumen, providing a barrier and filtration system for cerebrospinal fluid; slowly proliferating stem cells; actively proliferating progenitor cells; and proliferating neuroblasts (Doetsch et al., 1999; Seri et al., 2004) . Ependymal cells were proposed to be SVZ stem cells , but mounting evidence indicates that ependymal cells are not proliferative and do not have the properties of NPCs (Capela and Temple, 2002; Doetsch et al., 1999) . Since FXR2 expression is restricted to NPCs and Noggin expression is restricted to the ependymal cells, this differential expression prevents the direct regulation of Noggin expression by FXR2. We detected very low levels of Noggin protein in the early passage SVZ-NPCs, which could be due to contamination of residual ependymal cells during SVZ dissection.
The DG lies deep within the hippocampal parenchyma. neuroblasts in the DG (Kriegstein and Alvarez-Buylla, 2009; Ming and Song, 2005; Seri et al., 2004; Zhao et al., 2008) . We found that Noggin and FXR2 are colocalized in the DG type 1 cells and FXR2 deficiency leads to increased proliferation of these cells. An ependymal-equivalent cell type has not been found in the DG. However, the neurons in the DG are in much closer proximity to stem cells compared with those in the SVZ; therefore, granule neurons may create a plausible stem cell niche in the DG, and increased neuronal Noggin expression in the DG neurons of Fxr2 KO mice may be partially responsible for the phenotypes of DG-NPCs in Fxr2 KO mice. In summary, our data support the notion that the differences both in the intrinsic properties of NPCs and in the stem cell niche may contribute to the differences in neurogenesis seen between the DG and the SVZ.
FXR2, Noggin, and BMP Signaling May be Key Components of the Mechanism Underlying Differential Regulation of Adult DG and SVZ NPCs Noggin plays important roles in many types of stem cells and helps maintain pluripotency in cultured stem cells (Chambers et al., 2009; Chaturvedi et al., 2009) . With regard to adult neurogenesis, Noggin inhibits BMP signaling to promote NPC proliferation and neuronal differentiation, while inhibiting glial differentiation (Chmielnicki et al., 2004; Lim et al., 2000) . Our data, together with previous study (Bonaguidi et al., 2008) , suggest that Noggin and BMP may be key components of the mechanism underlying the differential regulation of DG and SVZ neurogenesis. Bonaguidi et al. (2008) demonstrated that DG-NPCs have a high level of intrinsic BMP signaling and that Noggin promotes the proliferation of isolated DG-NPCs; they concluded that Noggin is responsible for maintaining the selfrenewal of type 1 DG stem cells in vivo (Bonaguidi et al., 2008) . This finding is consistent with our observation that Fxr2 KO mice exhibited increased Noggin expression and selfrenewal of Type 1 cells in the DG. Both the findings of Bonaguidi et al. (2008) and those of the present study show that Noggin has no effect on the proliferation of SVZ-NPCs; however, our interpretation of this result is different. Bonaguidi et al. (2008) proposed that this lack of an effect from Noggin might be due to the very low level of intrinsic BMP signaling in SVZ-NPCs, but they did not analyze the effect of Noggin and BMP on the differentiation of SVZ-NPCs. We found that, although Noggin has no effect on the proliferation of SVZ-NPCs, it has similar effects on the differentiation of both DG-NPCs and SVZ-NPCs, consistent with the literature (Chmielnicki et al., 2004; Lim et al., 2000) . We also found that exogenous BMP2 had similar effects on both the proliferation and differentiation of both DG-NPCs and SVZ-NPCs. Therefore, our data suggest that the BMP signal transduction pathway is intact in both DGNPCs and SVZ-NPCs. The lack of any effect from Noggin manipulation on SVZ-NPC proliferation could stem from other causes, such as the presence of another yet-to-be-identified inhibitor of BMP signaling in SVZ-NPCs. Based on our data, we suggest that the main reason FXR2 deficiency has no effect on SVZ-NPCs is simply because FXR2 does not regulate Noggin expression in the SVZ. Spencer et al., 2006) , circadian rhythm changes (Zhang et al., 2008) , and synaptic transmission alterations (Zhang et al., 2009 ). On the other hand, evidence also points to different functions for FXR2 and FMRP. For example, loss of FMRP expression leads to alterations in long-term synaptic plasticity, including enhanced mGluR-dependent long-term depression (LTD) in hippocampal CA1 cells, as well as loss of protein synthesisdependence for its maintenance (Hou et al., 2006; Huber et al., 2002; Nosyreva and Huber, 2006) . Surprisingly, Fxr2 KO mice have decreased mGluR-LTD that remains protein synthesis dependent, whereas FMRP and FXR2 double mutant mice have a dramatically exaggerated LTD (Zhang et al., 2009) . It is likely that FXR2 and FMRP are functioning in different pathways that could synergistically affect certain biological processes, despite their opposite individual effects. In a similar situation, we previously showed that FMRP deficiency in mice leads to impaired hippocampal neurogenesis and hippocampal-dependent learning and that FMRP regulates DG-NPCs via the Wnt signaling pathway (Guo et al., 2011; Luo et al., 2010 , and loss of FXR2 only affects stem cell proliferation in the DG. Therefore, both FMRP and FXR2 can regulate adult hippocampal NPCs by binding to the mRNAs of NPC regulators, but their mechanisms, as well as their functional outputs, are different. Posttranscriptional regulation of critical regulatory mRNAs by RNA-binding proteins is likely to be a common mechanism during critical cellular processes (Bhattacharyya et al., 2008; Callan et al., 2010; Tervonen et al., 2009; Yang et al., 2009 ), but evidence for this in adult mammalian neurogenesis is rather limited. Our data are among the first to demonstrate that RNA-binding proteins can play important roles in the differential regulation of NPCs residing in different adult brain regions. Future studies examining the role of FXR2 in generating the inhibitory interneurons of the olfactory bulb and excitatory neurons of the DG, particularly in comparison with FMRP, will further contribute to our knowledge of these important RNA-binding proteins in adult neurogenesis and plasticity.
EXPERIMENTAL PROCEDURES Mice
All animal procedures were performed according to protocols approved by the University of New Mexico Animal Care and Use Committee. The Fxr2 KO mouse strain on the C57B/L6 genetic background published previously (Bontekoe et al., 2002) was obtained from the Emory University fragile X consortium. The Noggin LacZ transgenic mice were maintained and genotyped as described previously (Stottmann et al., 2001 ).
In Vivo Cell Proliferation, Differentiation Analysis, and Immunohistology In vivo neurogenesis analyses were performed essentially as we have previously described (Guo et Isolation, Culture, and In Vitro Analyses of Adult NPCs NPCs used in this study were isolated from the DG and SVZ of 8-to 10-weekold male Fxr2 KO mice and WT littermate controls based on published methods (Babu et al., 2007; Bull and Bartlett, 2005; Luo et al., 2010; Seaberg and van der Kooy, 2002) . NPC maintenance, proliferation and differentiation analyses, and neurosphere assays were performed as described in our publications (Barkho et al., 2008; Liu et al., 2010; Luo et al., 2010; Szulwach et al., 2010) .
Cell Transfection and Luciferase Assay
Transfection of NPCs was performed using a Stemfect kit (Stemgent, San Diego, CA), and luciferase activity was detected using the Dual-Luciferase Reporter 1000 System (Promega, # E1980), based on the manufacturer's protocols and our publications (Liu et al., 2010; Smrt et al., 2010) .
In Vivo and In Vitro Acute Knockdown of FXR2 in NPCs Using FXR2-siRNA For in vivo acute knockdown of FXR2, retroviral grating was performed as described (Liu et al., 2010; Smrt et al., 2007; Smrt et al., 2010; Szulwach et al., 2010) .
RNA Immunoprecipitation
RNA-IP was performed as described (Brown et al., 2003; Luo et al., 2010) . WT and Fxr2 KO NPCs (2 3 10 6 ) and a monoclonal antibody against FXR2 (F1554, Sigma-Aldrich) were used.
RT-PCR, Real-Time PCR, and Neural Stem Cell Pathway Arrays RT-PCR and real-time PCR were performed using standard methods as described (Liu et al., 2010; Luo et al., 2010) . Differential gene expression in Fxr2 KO DG-NPCs was determined using mouse Neural Stem Cell Pathway Arraya (QIAGEN) according to the manufacturer's instructions (QIAGEN).
Actinomycin D Treatment (Noggin mRNA Stability Assay) DG-NPCs were treated with 10 mg/ml of actinomycin D (Sigma-Aldrich) to inhibit gene transcription, based on a published method (Ghosh et al., 2009) , and cells were collected at various time intervals. Noggin mRNA levels normalized to GAPDH were assessed by real-time PCR.
In Vitro Transcription of Biotin-Labeled Noggin mRNA and Binding Assay Performance of this procedure was based on a previously published method with minor modifications (Deschenes-Furry et al., 2007) .
ELISA Analysis of Secreted Noggin
To determine the amount of secreted Noggin protein in the cell medium, medium was collected after 24 hr of culture. Determination of secreted Noggin was performed using a mouse Noggin ELISA kit (ABIN425343, antibodies-online.com, Atlanta, USA), according to the manufacturer's instructions.
Treating NPCs with Exogenous Noggin and BMP2, Anti-Noggin Blocking Antibody, and Conditioned Medium For growth factor and antibody treatment, the concentration of Noggin was 250 ng/ml (R&D Systems), BMP2 was 25 ng/ml (R&D Systems), and Noggin antibody was 2.5 ng/ml (R&D Systems). Conditioned medium was collected from WT and KO DG-NPCs after 24 hr in culture.
Recombinant Lentivirus and In Vivo Lentiviral Grafting
Lentivirus expressing control shRNA (shCon) was published previously (Barkho et al., 2008; Liu et al., 2010) . Noggin-shRNA plasmids were purchased (QIAGEN), and their efficiency at knocking down endogenous Noggin was tested by transfecting P19 cells followed by Western blotting analyses. The shRNA exhibiting highest efficacy was then cloned into the lentiviral vector, and in vivo lentiviral grafting was performed as described (Liu et al., 2010; Smrt et al., 2007; Smrt et al., 2010; Szulwach et al., 2010) . Based on the published criteria (Clelland et al., 2009) , only animals with lentivirus-infected (GFP + ) cells in >50% of the DG area of the adult hippocampus were included in the data analysis shown in Figure 7 .
Statistical Analysis
Statistical analysis was performed using ANOVA and Student's t test, unless specified, with the aid of SPSS version 17. All percentages were arcsine-transformed before statistical analysis. The Bonferroni correction was used to control type I error (Rice, 1989) . We first normalized the treatment group by the control group for RT-PCR, and then one-sample t test against mean of 1 was used on the normalized values. All data were shown as mean with standard error of mean (mean ± SEM). Probabilities of p < 0.05 were considered as significant.
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